New Cancer Research Reported from University of Geneva (S-acylation of Ca2+ transport proteins in cancer).

A recent report from the University of Geneva discusses the role of S-acylation of Ca2+ transport proteins in cancer development and progression. The research highlights how alterations in cellular calcium signals are linked to various types of cancers and how S-acylation enzymes play a role in modulating the activity of Ca2+ transporters. The study compiles evidence of the association between Ca2+ transport proteins, S-acylation enzymes, and specific cancers, shedding light on the potential oncogenic impact of S-acylation in cancer. For more information, the full article is available in Chronic Diseases and Translational Medicine. [Extracted from the article]